{"id":121254,"date":"2026-06-28T20:40:32","date_gmt":"2026-06-28T17:40:32","guid":{"rendered":"https:\/\/ainalalam.com\/?p=121254"},"modified":"2026-06-28T20:40:32","modified_gmt":"2026-06-28T17:40:32","slug":"wegovy%ef%b8%8f-pill-prescriptions-surpass-3-million-1-filled-roughly-every-5-seconds-bringing-glp-1-therapy-to-people-with-obesity-previously-untreated-while-novo-nordisk-unveils-new-data-at","status":"publish","type":"post","link":"https:\/\/ainalalam.com\/?p=121254","title":{"rendered":"Wegovy\u00ae\ufe0f pill prescriptions surpass 3 million, 1 filled roughly every 5 seconds, bringing GLP-1 therapy to people with obesity previously untreated, while Novo Nordisk unveils new data at ADA 2026"},"content":{"rendered":"[mhc_section admin_label=”\u0642\u0633\u0645” fullwidth=”on” specialty=”off”][mhc_fullwidth_menu admin_label=”\u0642\u0627\u0626\u0645\u0629 \u0628\u0639\u0631\u0636 \u0643\u0627\u0645\u0644” menu_id=”56″ background_color=”#ffffff” background_layout=”light” text_orientation=”center” submenu_direction=”downwards” fullwidth_menu=”off”] [\/mhc_fullwidth_menu][\/mhc_section][mhc_section admin_label=”section” transparent_background=”off” gradient_background=”off” background_color=”#ffffff” gradient_style=”horizontal” inner_shadow=”on” parallax=”off” parallax_method=”off” video_hide=”off” video_pause=”off” allow_advanced_padding=”on” remove_padding=”on” force_fullwidth=”off” column_paddings=”padding-0pct” column_match_heights=”off” background_leak=”off” background_leak_color=”#ffffff” background_leak_size=”25″ separator_top=”off” separator_bottom=”off” background_image_size=”cover” background_image_repeat=”no-repeat” background_image_position_x=”center” background_image_position_y=”center” animation=”off” animation_color=”#ffffff” mobile_2_pr_row=”off” mobile_reverse=”off”][mhc_row admin_label=”row”][mhc_column type=”1_3″][mhc_image admin_label=”\u0635\u0648\u0631\u0629” src=”https:\/\/ainalalam.com\/wp-content\/uploads\/2024\/04\/ainlogo.png” show_in_lightbox=”off” url_new_window=”off” animation=”off” hoverfx=”scaleup” sticky=”off” image_mask=”off” border_radius=”0″ align=”center” force_center_on_mobile=”on” alt=”\u0645\u0648\u0642\u0639 \u0639\u064a\u0646 \u0627\u0644\u0639\u0627\u0644\u0645 \u0647\u0648 \u0645\u0648\u0642\u0639 \u062a\u0633\u0648\u064a\u0642\u064a \u0648\u0641\u0642 \u0648\u062b\u064a\u0642\u0629 \u0627\u0644\u0639\u0645\u0644 \u0627\u0644\u062d\u0631.”] [\/mhc_image][\/mhc_column][mhc_column type=”2_3″][mhc_ticker admin_label=”\u0634\u0631\u064a\u0637 \u0623\u062e\u0628\u0627\u0631” magazine_list=”date” offset_posts=”0″ ticker_title=”\u062c\u062f\u064a\u062f \u0627\u0644\u062a\u063a\u0637\u064a\u0627\u062a” background_layout=”dark” background=”#6d3a2a” show_thumbnail=”on” show_arrows=”on” auto=”off” fade=”fade” pause=”off”] [\/mhc_ticker][\/mhc_column][\/mhc_row][\/mhc_section][mhc_section admin_label=”\u0642\u0633\u0645” fullwidth=”on” specialty=”off” transparent_background=”off” gradient_background=”off” background_color=”#1e6eb5″ gradient_style=”horizontal” inner_shadow=”off” parallax=”off” parallax_method=”off” video_hide=”off” video_pause=”off” allow_advanced_padding=”off” remove_padding=”off” force_fullwidth=”off” column_paddings=”padding-0pct” column_match_heights=”off” background_leak=”off” background_leak_color=”#ffffff” background_leak_size=”50″ separator_top=”off” separator_bottom=”off” background_image_size=”cover” background_image_repeat=”no-repeat” background_image_position_x=”center” background_image_position_y=”center” animation=”off” animation_color=”#ffffff” mobile_2_pr_row=”off” mobile_reverse=”off”][mhc_fullwidth_search_bar admin_label=”\u0634\u0631\u064a\u0637 \u0628\u062d\u062b \u0628\u0639\u0631\u0636 \u0643\u0627\u0645\u0644” post_type=”all” show_terms=”off” terms_tax=”post_tag” placeholder=”\u0639\u064a\u0646 \u0627\u0644\u0639\u0627\u0644\u0645” icon_color=”#1e6eb5″ background_layout=”dark” border_radius=”6″ custom_paddings=”13px” animation=”off”] [\/mhc_fullwidth_search_bar][\/mhc_section][mhc_section admin_label=”\u0642\u0633\u0645” fullwidth=”on” specialty=”off” transparent_background=”off” gradient_background=”off” background_color=”#ffffff” gradient_style=”horizontal” inner_shadow=”off” parallax=”off” parallax_method=”off” video_hide=”off” video_pause=”off” allow_advanced_padding=”off” remove_padding=”off” force_fullwidth=”off” column_paddings=”padding-0pct” column_match_heights=”off” background_leak=”off” background_leak_color=”#ffffff” background_leak_size=”50″ separator_top=”off” separator_bottom=”off” background_image_size=”cover” background_image_repeat=”no-repeat” background_image_position_x=”center” background_image_position_y=”center” animation=”off” animation_color=”#ffffff” mobile_2_pr_row=”off” mobile_reverse=”off”][mhc_fullwidth_post_header admin_label=”\u0639\u0646\u0648\u0627\u0646 \u0627\u0644\u0645\u0642\u0627\u0644\u0629 \u0628\u0639\u0631\u0636 \u0643\u0627\u0645\u0644” title=”on” meta=”off” avatar=”on” author=”on” date=”on” categories=”on” comments=”off” views=”off” show_ratings=”off” show_excerpt=”off” show_share=”on” text_orientation=”center” text_color=”dark” featured_image=”on” featured_placement=”below” parallax=”off” parallax_method=”off” animation=”bouncein” custom_paddings=”40″ size=”26px” title_bold=”on” text_shadow=”off” text_background=”off” text_bg_color=”#ffffff” overlay=”on” bg_color=”rgba(255,255,255,0.81)”] [\/mhc_fullwidth_post_header][\/mhc_section][mhc_section admin_label=”\u0642\u0633\u0645” fullwidth=”off” specialty=”off” transparent_background=”off” gradient_background=”off” background_color=”#ffffff” gradient_style=”horizontal” inner_shadow=”off” parallax=”off” parallax_method=”off” video_hide=”off” video_pause=”off” allow_advanced_padding=”off” remove_padding=”off” force_fullwidth=”off” column_paddings=”padding-0pct” column_match_heights=”off” background_leak=”off” background_leak_color=”#ffffff” background_leak_size=”50″ separator_top=”off” separator_bottom=”off” background_image_size=”cover” background_image_repeat=”no-repeat” background_image_position_x=”center” background_image_position_y=”center” animation=”off” animation_color=”#ffffff” mobile_2_pr_row=”off” mobile_reverse=”off”][mhc_row admin_label=”\u0635\u0641”][mhc_column type=”1_3″][\/mhc_column][mhc_column type=”2_3″][mhc_text admin_label=”\u0646\u0635” background_layout=”light” text_orientation=”left” animation=”off”]\n

Ain Alalam – Rashad Iskandrni<\/p>\n

\n

Three million prescriptions for Wegovy\u00ae\ufe0f pill since launch on January 5th serve as another milestone in one of the strongest US pharmaceutical launches by volume on record1<\/p>\n

The majority of new Wegovy\u00ae\ufe0f pill prescriptions are for people new to GLP-1 therapy, bringing obesity medicine to many previously untreated1<\/p>\n

This news comes as Novo Nordisk has a large presence at the American Diabetes Association\u2019s 2026 Scientific Sessions, including a variety of Wegovy\u00ae\ufe0f analyses in adults with obesity<\/p>\n

\n

Novo Nordisk today announced Wegovy\u00ae\ufe0f (semaglutide) tablets 25 mg have surpassed three million prescriptions in just over five months, establishing Wegovy\u00ae\ufe0f pill as one of the strongest US pharmaceutical launches by volume on record.\u00b9 The three million milestone corresponds to one prescription filled roughly every five seconds, reflecting continued uptake since Wegovy\u00ae\ufe0f pill became available in January 2026. Further underscoring its rapid adoption, Wegovy\u00ae\ufe0f pill reached its initial one million prescription milestone just 12 weeks after reaching US pharmacies and online providers (week of 1\/5\/26 to week of 3\/23\/26), with an additional two million prescriptions accumulated in an even shorter span of just 10 weeks (week of 3\/23\/26 to week of 6\/1\/26). The majority of new prescriptions filled for Wegovy\u00ae\ufe0f pill (more than 80%) are for people new to GLP-1 therapy, indicating the oral formulation is expanding the obesity treatment market, rather than replacing existing therapies.\u00b9<\/p>\n

\n

\u201cWegovy\u00ae\ufe0f offers adults with obesity significant weight loss, along with diet and exercise, and is FDA-approved to lower the risk of major cardiovascular events such as death, heart attack, or stroke in adults with obesity with known heart disease \u2013 making Wegovy\u00ae\ufe0f pill truly distinct. With Wegovy\u00ae\ufe0f pill and Wegovy\u00ae\ufe0f HD available for weight management, patients and their healthcare providers are making choices that fit their needs, resulting in the clear adoption for both treatments,\u201d said Jamey Millar, executive vice president, US Operations of Novo Nordisk. \u201cNovo Nordisk remains determined to continue playing a major part in addressing the global public health challenge of obesity by deeply understanding the needs of those who live with it. That is why we are at ADA 2026 – to talk to patients, healthcare professionals, and investors to present our data but also listen and learn\u201d<\/p>\n

\n

This year, more patients starting a new weight management therapy have filled prescriptions for Wegovy\u00ae\ufe0f than any other available obesity medication. Alongside the three million prescription milestone for Wegovy\u00ae\ufe0f pill, the recently launched Wegovy\u00ae\ufe0f HD (semaglutide) injection 7.2 mg has demonstrated strong uptake in the early days of availability.1<\/p>\n

\n

Expanding affordable access to medicines is a priority for Novo Nordisk, including the expansion of coverage for those with insurance in the US. Those with commercial insurance coverage can access Wegovy\u00ae\ufe0f for as little as $25 per month through existing savings programs.* The recently announced Medicare GLP-1 Bridge builds on these efforts to expand access and will provide eligible Medicare beneficiaries living with obesity access to Wegovy\u00ae\ufe0f (semaglutide) injection and tablets for a $50 monthly copay\u2020, beginning July 1, 2026. In addition, Wegovy\u00ae\ufe0f is available through a range of access options, including more than 70,000 US pharmacies, NovoCare\u00ae\ufe0f Pharmacy, select telehealth providers, and others<\/p>\n

\n

This announcement coincides with Novo Nordisk presenting an array of clinical data at the American Diabetes Association\u00ae\ufe0f 2026 86th Scientific Sessions in New Orleans (June 5-8, 2026), including a variety of Wegovy\u00ae\ufe0f analyses in adults with obesity<\/p>\n

\n

Novo Nordisk is preparing for the first launches of the Wegovy\u00ae\ufe0f pill outside the United States in the second half of 2026, including the recently announced approval and launch in the United Arab Emirates<\/p>\n

\n

Investor relations event<\/p>\n

Novo Nordisk will host an investor event covering ADA 2026 data and the Wegovy\u00ae\ufe0f pill commercial milestone on 7 June 7, 2026 at 6:30 pm CDT. The event will be accessible via live webcast on the Novo Nordisk investor website<\/p>\n

\n

*Pay as little as $25, subject to a maximum savings of $100\/month. Eligibility and restrictions apply. Government beneficiaries excluded. Month defined as 1 box of 4 pens of Wegovy\u00ae\ufe0f and 1 bottle of 30 tablets of Wegovy\u00ae\ufe0f. Novo Nordisk reserves the right to modify or cancel this program at any time. See full terms at WegovyTerms.com and NovoCarePharmacyTerms.com<\/p>\n

\u2020Terms apply. For eligible Medicare patients prescribed Wegovy\u00ae\ufe0f for a covered FDA-approved indication. Eligibility criteria will be determined by CMS. This information is not a guarantee of coverage. Month defined as 1 box of 4 pens of Wegovy\u00ae\ufe0f and 1 bottle of 30 tablets of Wegovy\u00ae\ufe0f<\/p>\n[\/mhc_text][\/mhc_column][\/mhc_row][\/mhc_section]\n","protected":false},"excerpt":{"rendered":"

[mhc_section admin_label=”\u0642\u0633\u0645” fullwidth=”on” specialty=”off”][mhc_fullwidth_menu admin_label=”\u0642\u0627\u0626\u0645\u0629 \u0628\u0639\u0631\u0636 \u0643\u0627\u0645\u0644” menu_id=”56″ background_color=”#ffffff” background_layout=”light” text_orientation=”center” submenu_direction=”downwards” fullwidth_menu=”off”] [\/mhc_fullwidth_menu][\/mhc_section][mhc_section admin_label=”section” transparent_background=”off” gradient_background=”off” background_color=”#ffffff” gradient_style=”horizontal” inner_shadow=”on” parallax=”off” parallax_method=”off” video_hide=”off” video_pause=”off” allow_advanced_padding=”on” remove_padding=”on” force_fullwidth=”off” column_paddings=”padding-0pct” column_match_heights=”off” background_leak=”off” background_leak_color=”#ffffff” background_leak_size=”25″ separator_top=”off” separator_bottom=”off” background_image_size=”cover” background_image_repeat=”no-repeat” background_image_position_x=”center” background_image_position_y=”center” animation=”off” animation_color=”#ffffff” mobile_2_pr_row=”off” mobile_reverse=”off”][mhc_row admin_label=”row”][mhc_column type=”1_3″][mhc_image admin_label=”\u0635\u0648\u0631\u0629” src=”https:\/\/ainalalam.com\/wp-content\/uploads\/2024\/04\/ainlogo.png” show_in_lightbox=”off” url_new_window=”off” animation=”off” hoverfx=”scaleup” sticky=”off” image_mask=”off” border_radius=”0″ align=”center” force_center_on_mobile=”on” […]<\/p>\n","protected":false},"author":1,"featured_media":121255,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[49],"tags":[],"class_list":["post-121254","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-coverage"],"_links":{"self":[{"href":"https:\/\/ainalalam.com\/index.php?rest_route=\/wp\/v2\/posts\/121254","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ainalalam.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ainalalam.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ainalalam.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/ainalalam.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=121254"}],"version-history":[{"count":1,"href":"https:\/\/ainalalam.com\/index.php?rest_route=\/wp\/v2\/posts\/121254\/revisions"}],"predecessor-version":[{"id":121256,"href":"https:\/\/ainalalam.com\/index.php?rest_route=\/wp\/v2\/posts\/121254\/revisions\/121256"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ainalalam.com\/index.php?rest_route=\/wp\/v2\/media\/121255"}],"wp:attachment":[{"href":"https:\/\/ainalalam.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=121254"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ainalalam.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=121254"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ainalalam.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=121254"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}